secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2026-08-17T12:35:37+00:00
Accession:  0001493152-26-038648
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Fertility Q2 2026 revenue up 17% to $2.18M; net income $0.9M vs $3.6M loss
-------------------------------------------------------------------------------

- Revenue $2,175,485, up 17% YoY; clinic revenue $2,167,785, up 18% from $1,832,094.
- Net income $0.9M vs $(3.6)M loss; includes ~$2.5M gain on Birmingham acquisition remeasurement.
- Clinic-Level Adjusted EBITDA $333K in Q2 vs $164K in Q1; $951K for FY 2025.
- Adjusted EBITDA $(1.0)M vs $(0.6)M; cash $3.7M at June 30, 2026.
- Birmingham clinic now wholly owned after June 2026 acquisition of remaining interests.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315226038648/0001493152-26-038648-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315226038648/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-038648

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer